We previously showed that IL-15:IL15Rα-secreting cell-based cancer vaccine surpassed those expressing IL-15 alone for eliminating tumors, preventing tumor recurrence and enhancing overall survival of tumor-bearing mice in CT26 colon cancer cells [3]. This evidence concerns the gene IL15RA and malignant colon neoplasm.